Murine cytomegalovirus-Pseudomonas synergistic infections: comparison of virulent and attenuated virus
- PMID: 2825950
- DOI: 10.1139/m87-161
Murine cytomegalovirus-Pseudomonas synergistic infections: comparison of virulent and attenuated virus
Abstract
The synergistic interactions between Pseudomonas aeruginosa and virulent or attenuated murine cytomegalovirus (MCMV) were compared in vivo. Virulent MCMV challenge at a dose of 5 X 10(5) pfu/mouse intraperitoneally, followed by intranasal superinfection with 5 X 10(6) cfu/mouse of Pseudomonas aeruginosa after 48 h resulted in greater than 80% mortality, apparently owing to a failure of pulmonary clearance mechanisms. Single infections, or the use of attenuated MCMV in synergistic infections, did not result in significant morbidity or mortality. Infection with virulent MCMV in vivo resulted in the rapid spread of virus to the lung, liver, and spleen, followed later by spread to the salivary glands. Attenuated virus was detected in salivary glands only. Virulent MCMV was more effective in adsorbing to, or infecting, spleen cells in vitro than attenuated virus. Viral neutralization experiments using anti-viral serum, rabbit complement, and anti-mouse IgG confirmed the presence of a nonneutralizing antibody on the surface of the virulent virus. Our results suggest that the presence of the nonneutralizing antibody on virulent MCMV allows the virus to preferentially infect, or adsorb to, Fc+ cells in the peritoneum. These cells may then carry the virus, via the lymphatic circulation, to other areas of the body, resulting in the replication of virus in multiple organs. Virus replication in the lung may, in part, be the cause of the observed suppression of pulmonary clearance.
Similar articles
-
Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.J Gen Virol. 1988 Aug;69 ( Pt 8):1987-98. doi: 10.1099/0022-1317-69-8-1987. J Gen Virol. 1988. PMID: 2841411
-
Murine model for immunoprophylaxis of cytomegalovirus infection. I. Efficacy of immunization.Microbiol Immunol. 1978;22(11):693-700. doi: 10.1111/j.1348-0421.1978.tb00422.x. Microbiol Immunol. 1978. PMID: 85239
-
Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections.Infect Immun. 1976 Oct;14(4):982-9. doi: 10.1128/iai.14.4.982-989.1976. Infect Immun. 1976. PMID: 186411 Free PMC article.
-
Adverse effects of cytomegalovirus vaccination in mice.J Clin Invest. 1980 Apr;65(4):798-803. doi: 10.1172/JCI109730. J Clin Invest. 1980. PMID: 6244333 Free PMC article.
-
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.Arch Virol. 1979;62(1):1-29. doi: 10.1007/BF01314900. Arch Virol. 1979. PMID: 231945 Review. No abstract available.
Cited by
-
Reduced expression of gamma interferon in serum and marked lymphoid depletion induced by Porphyromonas gingivalis increase murine morbidity and mortality due to cytomegalovirus infection.Infect Immun. 2004 Oct;72(10):5791-8. doi: 10.1128/IAI.72.10.5791-5798.2004. Infect Immun. 2004. PMID: 15385479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical